DAVID N GILL Insider Trading $HSGX Ocugen, Inc.
Get free email notifications about insider trading for DAVID N GILL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID N GILL. DAVID N GILL is Senior Vice President and CFO in CTI MOLECULAR IMAGING INC ($CTMI) and in STRATA Skin Sciences, Inc. ($MELA) and Director in STRATA Skin Sciences, Inc. ($MELA) and Director in HISTOGENICS CORP ($HSGX) and Director in CEMPRA, INC. ($CEMP) and Director in Evolus, Inc. ($EOLS) and Chief Financial Officer in EndoChoice Holdings, Inc. ($GI) and President and CFO in EndoChoice Holdings, Inc. ($GI) and Director in Strongbridge Biopharma plc ($SBBP) and Director in Y-mAbs Therapeutics, Inc. ($YMAB).
DAVID N GILL in Ocugen, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID N GILL: Director
Holdings: 14,000 shares
Current Value: $23,240
Latest Transaction: Jun 19 2018
$HSGX Market Capitalization: $28.25M
$HSGX Previous Close: $1.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID N GILL in Ocugen, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CTMI, GI, EOLS, MLNT, HSGX, MELA, SBBP, YMAB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 19 2018 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | A | 2.97 | 25,000 | 74,250 | 25,000 | |
| Aug 17 2017 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | P | 1.81 | 3,000 | 5,439 | 14,000 | 11 K to 14 K (+27.27 %) |
| Jun 14 2017 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | A | 1.70 | 25,000 | 42,500 | 25,000 | |
| May 17 2017 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | P | 1.68 | 3,000 | 5,040 | 11,000 | 8 K to 11 K (+37.50 %) |
| Dec 19 2016 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
| Dec 15 2016 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | P | 1.65 | 3,000 | 4,950 | 8,000 | 5 K to 8 K (+60.00 %) |
| Dec 15 2016 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | P | 1.92 | 5,000 | 9,600 | 5,000 | 0 to 5 K |
| Jun 26 2015 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | A | 6.86 | 6,800 | 46,648 | 6,800 |
Page: 1